SARMS

New Sarms SR-9011   SR9011 is a research drug that was developed by Professor Thomas Burris of Scripps as an agonist of Rev-ErbAα with a half-maximum inhibitory concentration (IC50) = 790 nM… Read More »New Sarms SR-9011

Ibutamoren mesylate (MK-0677) Ibutamoren Mesylate MK677 an orally active nonpeptide growth hormone (GH) secretagogue, stimulates GH release through a pituitary and hypothalamic receptor that is… Read More »Ibutamoren Mesylate